John E. Davis - 23 Feb 2024 Form 4 Insider Report for ARTIVION, INC. (AORT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
26 Feb 2024, 18:10:53 UTC
Prior SEC filing
22 Feb 2024
Next SEC filing
29 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John E. Davis

Key filing fact

John E. Davis filed Form 4 for ARTIVION, INC. (AORT) on 26 Feb 2024.

Key facts

  • This page summarizes John E. Davis's Form 4 filing for ARTIVION, INC. (AORT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 26 Feb 2024, 18:10.

Change

  • Previous filing in this sequence was filed on 22 Feb 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AORT transaction

Common Stock

Award

Transaction value
$0
Shares
+19,734
Change %
+15%
Price
$0.000000
Shares after
147,911
Date
23 Feb 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .